Credit Suisse’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-52,328
| Closed | -$411K | – | 3104 |
|
|
2023
Q3 | $411K | Sell |
52,328
-6,249
| -11% | -$49.1K | ﹤0.01% | 2776 |
|
|
2023
Q2 | $585K | Buy |
58,577
+31,177
| +114% | +$311K | ﹤0.01% | 2680 |
|
|
2023
Q1 | $243K | Buy |
27,400
+9
| +0% | +$80 | ﹤0.01% | 3045 |
|
|
2022
Q4 | $301K | Sell |
27,391
-1,459
| -5% | -$16K | ﹤0.01% | 3024 |
|
|
2022
Q3 | $376K | Buy |
28,850
+13,231
| +85% | +$172K | ﹤0.01% | 2946 |
|
|
2022
Q2 | $197K | Buy |
15,619
+1,145
| +8% | +$14.4K | ﹤0.01% | 3319 |
|
|
2022
Q1 | $203K | Buy |
14,474
+779
| +6% | +$10.9K | ﹤0.01% | 3353 |
|
|
2021
Q4 | $396K | Sell |
13,695
-3
| -0% | -$87 | ﹤0.01% | 3172 |
|
|
2021
Q3 | $411K | Buy |
13,698
+3,385
| +33% | +$102K | ﹤0.01% | 3111 |
|
|
2021
Q2 | $273K | Buy |
10,313
+487
| +5% | +$12.9K | ﹤0.01% | 3313 |
|
|
2021
Q1 | $306K | Sell |
9,826
-7,956
| -45% | -$248K | ﹤0.01% | 3149 |
|
|
2020
Q4 | $584K | Buy |
+17,782
| New | +$584K | ﹤0.01% | 2899 |
|